CXCL9 and neoplasm: In vivo, Cxcl9 concentration was significantly higher in the ascites of Brca2−/−Cxcl9+ tumours than in the ascites of Brca2−/−Control tumours (median 3.0 vs. 1.6 pg/mL; P = 0.033; Fig. 3c).